Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine
 Disease Category: Psoriasis and Psoriatic Disorders
Location: United States, WA

Trial Information

Registry of subjects on Enbrel ® (etanercept) for Treatment of Psoriasis

Patients with moderate to severe Psoriasis with no previous treatment with Enbreal, Humeira, or any other anti TNF agents.

Patient Inclusion Criteria

  • Age: 18 years old or above
  • Patients with moderate to severe Psoriasis (Otherwise healthy)
  • In or around Seattle, Washington

Patient Exclusion Criteria

  • Previous use of Remicade, Enbrel or Humeira
  • The patient is responsible for obtaining the medication with his or her own insurance.

For more information,

Kashus Riazy, Clinical Research Coordinator
Dermatology Associates
1730 Minor Ave, Suite 1000
Seattle, WA 98101
Phone: 206-315-0371
Email: kriazy@daseattle.com

View Map

Research Center Information: Dermatology Associates

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.